Oracle asserts that mission-critical security must be inherently built into the database rather than added later, especially with the rise of agentic AI. Ashish Ray, SVP of product management at Oracle, highlighted that autonomous AI tasks require resilience that is baked into the system, emphasizing that old enterprise security protocols are no longer sufficient. The new Oracle AI Database 26ai introduces Platinum and Diamond tiers, significantly reducing failover times to ensure high availability and data protection for AI and agentic workloads.

Longview Asset Management, LLC, a former 10% owner of GENERAL DYNAMICS (GD), has filed a Form 4 to update its insider status. The filing indicates no common stock or derivative transactions, signifying a routine ownership update rather than a new buy or sell event. This Form 4 merely clarifies Longview's continued status as an insider, albeit one no longer actively trading GD shares.

Devon Energy (DVN) saw its stock rise by 1.77% after a six-day losing streak, reaching $46.03. This rally is attributed to investor confidence amid geopolitical tensions driving oil prices and the positive impact of its merger with Coterra Energy, which expands its presence in the Appalachian Basin. Despite analysts giving it a "Hold" rating, many recommend a "Buy" due to strong profitability and a potentially undervalued P/E ratio, further supported by the company's solid GF Score™ of 75/100.

Super Micro Computer is facing a federal securities lawsuit alleging that the company and two executives concealed risks related to billions of dollars in server sales ultimately diverted to China through an export-control evasion scheme. The lawsuit was filed after the Department of Justice unsealed an indictment against three individuals connected to Super Micro for their alleged involvement in systematically diverting AI-capable servers to Chinese customers without proper licenses. As a result, the company's stock fell significantly, causing investors to suffer substantial losses, and shareholders are encouraged to assess their legal options.

Vertex Pharmaceuticals faces potential challenges to its cystic fibrosis (CF) drug market dominance as other companies develop competing treatments, including gene therapies that could treat a wider patient population. Despite these threats and aggressive competition in the CF pipeline, Vertex's core franchise remains secure for the near future, and the company is actively diversifying its product lineup with new approvals in other disease areas. This strategic expansion aims to mitigate risks from future CF competition, making Vertex Pharmaceuticals an attractive stock, according to the article.

Royal Caribbean Group has officially launched a new philanthropic foundation to formalize its charitable efforts, building on decades of work supporting education, environmental initiatives, and local economies. The foundation's initial project is backing an emergency medicine residency program at Jackson Health System in South Florida. This initiative aligns with the company's broader "SEA the Future" framework, focusing on sustainability, community, and innovation, and highlights Royal Caribbean's long-standing commitment to global communities.

JPMorgan Chase & Co. has reduced its price target for Calix (NYSE:CALX) from $90.00 to $70.00 but maintained an "overweight" rating, suggesting a significant upside. Calix recently exceeded earnings estimates with $0.39 EPS on $272.4 million revenue and announced a $125 million share repurchase program. The stock currently trades around $49.63, with analysts giving it a "Moderate Buy" rating and an average consensus price target of $71.67.

JPMorgan Chase & Co. has raised its price target for Arista Networks (ANET) to $200 from $190, maintaining an "overweight" rating and suggesting a potential upside of over 25%. This comes after Arista Networks exceeded quarterly earnings and revenue expectations, demonstrating strong year-over-year revenue growth and profitability. Despite significant insider selling activity, the stock has received numerous "Buy" and "Strong Buy" ratings from various analysts.

Georgia Tech and The Coca-Cola Company are finalizing an agreement for Georgia Tech to acquire property along North Avenue, valued at $31.3 million. This acquisition, which includes a two-story brick building and an adjacent two-acre park, will help Georgia Tech meet its expansion needs for academic, research, and student purposes. The move comes as Georgia Tech experiences record enrollment applications and strengthens the long-standing relationship between the two Atlanta institutions.

GE HealthCare has expanded its collaboration with RadNet’s DeepHealth subsidiary to advance and commercialize AI-powered mammography tools globally. This initiative builds on their existing partnership by introducing DeepHealth’s enhanced AI-powered Breast Suite, including ProFound Pro and Safeguard Review, which aims to improve breast cancer detection and operational efficiency in screening programs. The companies will showcase their latest advancements at the SBI Annual Symposium, emphasizing personalized prevention and care for women through AI integration.